ERBB2 and gastric cancer: Meanwhile, Yuan et al. found out that HER2-related metabolic heterogeneity in GC is linked to ICI response in neoadjuvant chemotherapy, showing that the quiescent, aspartate, and glutamate subtypes are better responders [20].